Lento Bio Raises $680,000 In Oversubscribed Seed Round Led By Ichor Life Sciences
Amount Raised
$680,000
Round Type
Seed
Description
POTSDAM, NY / September 6, 2022 / Lento Bio, Inc., a preclinical pharmaceutical company developing small-molecule therapeutics to restore ocular lens flexibility and near-vision in presbyopia patients, announced today they have raised $680,000 in funding during their recent oversubscribed seed round. Ichor Life Sciences is the lead investor for the round, providing $400,000 in funding to Lento Bio.
Quick answer
Lento Bio raised $680,000 in a Seed round, dated September 6, 2022. Lento Bio is based in Potsdam, Brandenburg, Germany.
- How much did Lento Bio raise?
- Lento Bio raised $680,000 in a Seed round on September 6, 2022.
- What does Lento Bio do?
- Lento Bio is an Ichor portfolio company developing small-molecule therapeutic treatments for degenerative aging disorders, focused initially on developing AGE-breaking therapeutic eyedrops for presbyopia.
- Where is Lento Bio based and how big is it?
- Lento Bio is based in Potsdam, Brandenburg, Germany.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Lento Bio that raised within 45 days of this round, from Fundz verified event records.
- Orionis Biosciences raised $55M (Funding Round) on October 19, 2022.
- Insmed Incorporated raised an undisclosed amount (Funding Round) on October 19, 2022.
- SURGE Therapeutics raised $26M (Series A) on October 17, 2022.
- Mablink Bioscience raised $30M (Series A) on October 14, 2022.
- CTRL Therapeutics raised $7.5M on October 12, 2022.
- Neumora raised $112M (Series B) on October 11, 2022.
Who to call at Lento Bio, and when
A new round usually means Lento Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lento Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lento Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lento Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lento Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Lento Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.